
Spine Biologics Market Share will Increase US $2.5 Billion by 2022
The Global Spine Biologics Market is relied upon to surpass more than US$ 2.5 Billion by 2022, at a CAGR of 4.4% in the given conjecture time frame.
The Global Spine Biologics Market is relied upon to surpass more than US$ 2.5 Billion by 2022, at a CAGR of 4.4% in the given conjecture time frame.
Foot and ankle devices are used in the treatment of injuries, which are caused by diseases or disorders, such as osteoporosis, rheumatoid arthritis, osteoarthritis, diabetic foot, bunions, hammertoes, and several other diseases, like trauma and neurological disorders.
As with most of the Indian healthcare delivery and devices market, the orthopedic devices segment is also growing at a CAGR of 20 percent year-on-year compared to global average of less than 6 percent.